Peter Collins is Chief Executive Officer of ANGLE plc. Throughout his career, Peter has demonstrated a consistent record of building high-performing teams and driving commercial growth across international healthcare markets. As interim CEO, he joins the Company in a non-board capacity.
Peter brings over 25 years of experience in oncology drug and diagnostics development, having held senior executive positions across both private and publicly listed companies. He joins the Company following a series of successful leadership roles at leading oncology diagnostics organisations, including Chief Executive Officer at SAGA Diagnostics, Chief Business Officer at Inivata, Vice President, Biopharma Business Development at Guardant Health, and Head of Diagnostics at GSK.
LinkedIn